Meeting
2022 ASCO Genitourinary Cancers Symposium
Discordance of patient- and physician-reported toxicities in two prospective trials of stereotactic body radiotherapy (SBRT) for localized prostate cancer.
Authors
Akshat Patel
UT Southwestern Medical Center, Dallas, TX
Akshat Patel , Rohit R Badia , Armon Amini , Christopher Kung , Samuel B. Kusin , Sarah Neufeld , Samantha Mannala , Aurelie Garant , Raquibul Hannan , Robert D. Timmerman , Michael J. Zelefsky , Michael Ryan Folkert , Neil Bipinchandra Desai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 245)
DOI
10.1200/JCO.2022.40.6_suppl.245
Abstract #
245
Poster Bd #
L2
Abstract Disclosures